Smith & Nephew plc is a portfolio medical technology company. The Company is engaged in developing, manufacturing, marketing, and selling medical devices and services. It is focused on the repair, regeneration, and replacement of soft and hard tissue. The Company's segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip, knee and shoulder implants used to replace diseased, damaged or worn joints, robotics-assisted enabling technologies that empower surgeons, and trauma products used to stabilise severe fractures and correct bone deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.
é«ãå©çæé·
å瀟ã®çŽå©çã¯æ¥çããªãŒãããŠãããææ°ã®å¹ŽéçŽå©çã¯USD 6.16Bã§ãã
é«é
åœ
å瀟ã¯é«é
åœéæã§ãããææ°ã®é
åœæ§åã¯79.37%ã§ãã
å®å®é
åœ
å瀟ã¯éå»5幎éã«ãããç¶ç¶çã«é
åœã宿œããŠãããææ°ã®é
åœæ§åã¯79.37%ã§ãã
å²å®
åç€Ÿã®ææ°ã®PEã¯28.08ã§ãéå»3幎éã®æ°Žæºãšæ¯èŒããŠå®å€åã«ãããŸãã
æ©é¢æè³å®¶ã®å£²ãè¶ã
ææ°ã®æ©é¢æè³å®¶ã®ä¿ææ ªæ°ã¯30.95Mæ ªã§ãåååææ¯ã§27.07%æžå°ããŠããŸãã
ãµã©ã»ã±ã¿ã©ãŒãä¿æ
ã¹ã¿ãŒæè³å®¶ãµã©ã»ã±ã¿ã©ãŒã¯æ¬éæã10.59Mæ ªä¿æããŠããŸãã
åžå ޿޻åãæŽ»çº
å瀟ãžã®æè³å®¶ã®é¢å¿ãé«ãŸã£ãŠããã20æ¥éã®å£²è²·å転çã¯1.13ã§ãã